RB1 and prostate cancer: Notably, both UL97 RNAi and treatment with the UL97 kinase inhibitor maribavir resulted in reduced phosphorylation of Rb on Ser807/Ser811 in prostate cancer cells (Fig. 2H; Fig. S4G).